Cellzome (NYSE:GSK)

Company Profile

CellZome is a leader in the development and advancement of proteomics technologies. It was acquired by GlaxoSmithKline in 2012.

Company Info

  • HQ: Heidelberg, Germany
Founders and CEO:
  • Charlie Cohen
Index Team:
Website:
cellzome.com
Sector:
Healthcare
Status:
Exited